Listen Now

Topics Covered

  • Overview of CAR-T Cell Therapy
  • Understanding CARs – Chimeric Antigen Receptors
  • When to Consider CAR-T Cell Therapy as a Treatment Option for Lymphoma
  • Clinical Trials for CAR-T Cell Therapy
  • Discussion of CAR-T Cell Therapy
  • Managing Potential Treatment Side Effects
  • Specific Examples of How CAR-T Cell Therapy May Contribute to Your Lymphoma Treatment Choices
  • Key Questions to Ask Your Health Care Team about CAR-T Cell Therapy
  • The Benefits of CAR-T Cell Therapy
  • Follow-Up Care: What to Expect
  • Questions for Our Panel of Experts

Our Panel of Experts

Nancy Bartlett, MD

Koman Chair in Medical Oncology, Professor, Department of Medicine, Oncology Division/Medical Oncology, Washington University School of Medicine in St. Louis

M. Lia Palomba, MD

Hematologist-Oncologist, Memorial Sloan Kettering Cancer Center, Associate Professor of Clinical Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College

Peggy Ann Torney

Chief Strategy, Communications and Engagement Officer, Lymphoma Research Foundation

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(89.1 KB)

Workshop Date

This workshop was originally recorded on November 16, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you will learn more about our use of cookies which help us make continuous improvements to our website. Learn more.